Just checked over on ABDX. Apparently it’s not them, it’s a company based in Abingdon. I was actually a bit bemused as to why our other collaborators weren’t on there too. I’m actually pleased it isn’t them in isolation.
I think the point yesterday is that most don’t disagree with charts, but yesterday’s rise which I see continuing is attributed to anticipation of news next week given upcoming presentation, website changes, recruitment & government road map. Let’s just say it was an easy one to call.
Your comments in the ODX board Hants which I agree with. I would therefor suggest the price is rising in anticipation of news rather than standard charting.
There's an Avacta presentation a week tomorrow which could also make interesting viewing for ODX holders. It may turn out to be a damp squib, but as news is overdue on many fronts, the results and being delivered 2 months sooner than they need to be and the CEO is doing an investor Q&A through choice - it seems likely that something is going to happen within the next few trading sessions.
Anyway, let’s get it CV’d & CE’d & let AS worry about demand & capacity. Quite sure he hasn’t been sat there thinking I hope the test works & if so, I’ll look at capacity later on. Can’t see it personally.
They’re in bed with Mologic, GAD, BBI, ODX (possibly), Medusa & that’s what we know at the moment. These companies combined are capable of making 10’s of millions of tests per month.